Defense Advanced Research Projects AgencyTagged Content List

Opportunities for Funding and/or Engagement

Relating to potential relationships with DARPA

Showing 2 results for Opportunities + Injury RSS
December 14, 2018, 10:00 AM ET,
Executive Conference Center
The Biological Technologies Office is holding a Proposers Day to provide information on the structure and objectives of the Panacea program. Panacea aims to integrate systems pharmacology and advanced medicinal chemistry approaches to expand the human drug target space for therapeutic interventions in the areas of acute management of pain and inflammation and the improvement of physiological endurance under oxygen-limited conditions or environments. Panacea will support the development and proof-of-concept demonstration of a new integrated platform for the rapid prediction, synthesis, and validation of pharmacological interventions.
10/29/2019
Military service members and veterans face serious occupational trauma; one element in particular relates to the significantly increased risk of acute and chronic neuropsychiatric conditions. Neuropsychiatric conditions in the military are particularly impactful because options for treating them are limited. No therapy currently exists that can deliver rapid relief of neuropsychiatric symptoms and is reasonable for use in a broad spectrum of conditions. Neuropsychiatric conditions are complex, and presentation is highly subject to significant inter-individual variability. Focused Pharma aims to develop new drugs that target specific neurotransmitter receptor signaling modes to deliver near immediate relief that is generalizable across indications and individuals.